Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
03/22/2012 | US20120071461 Substituted Benzamide Compounds |
03/22/2012 | US20120071459 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
03/22/2012 | US20120071450 Organic compounds |
03/22/2012 | US20120071449 Pharmaceutical composition for inhalation |
03/22/2012 | US20120071433 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives |
03/22/2012 | US20120071404 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds |
03/22/2012 | US20120071403 Methods for Treating Type 2 Diabetes in Patients Resistant to Previous Treatment with other Anti-Diabetic Drugs Employing an SGLT2 Inhibitor and Compositions Thereof |
03/22/2012 | US20120071399 Sulfation of wnt pathway proteins |
03/22/2012 | US20120071394 Novel polypeptides and use thereof |
03/22/2012 | US20120070521 Method of extraction from withania somnifera and one or more fractions containing pharmacologically active ingredients obtained therefrom |
03/22/2012 | US20120070520 Composition containing a bean extract for improving blood circulation and increasing vascular health |
03/22/2012 | US20120070519 Method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants |
03/22/2012 | US20120070515 Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder |
03/22/2012 | US20120070512 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives |
03/22/2012 | US20120070507 Compositions and Methods for the Treatment of Soft Tissue Injury |
03/22/2012 | US20120070501 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions |
03/22/2012 | US20120070472 Chronotherapeutic compositions and methods of their use |
03/22/2012 | US20120070471 Administration of enoxoparin sodium to patients 75 years and older with st-segment elevation myocardial infarction |
03/22/2012 | US20120070451 Methods and compositions for modulating cardiac contractility |
03/22/2012 | US20120070443 Pde1 as a target therapeutic in heart disease |
03/22/2012 | US20120070426 Peptide-based passive immunization therapy for the treatment of atherosclerosis |
03/22/2012 | US20120070403 Use of g-csf for the extension of the therapeutic time-window of thrombolytic stroke therapy |
03/22/2012 | US20120070390 Topical drug delivery system with dual carriers |
03/22/2012 | US20120070386 Trehalulose-containing composition, its preparation and use |
03/22/2012 | US20120070377 Compounds and biological materials and uses thereof |
03/22/2012 | US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma |
03/22/2012 | US20120070370 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors |
03/22/2012 | US20120070369 Hif inhibitors and use thereof |
03/22/2012 | DE102010040924A1 Substituierte Phenylacet- und Phenylpropanamide und ihre Verwendung Substituted Phenylacet- and Phenylpropanamide and their use |
03/22/2012 | CA2812184A1 Anthraquinone compounds and their uses |
03/22/2012 | CA2811242A1 Substituted phenylacetate and phenylpropane amides and use thereof |
03/22/2012 | CA2811186A1 High purity heparin and production method therefor |
03/21/2012 | EP2431403A1 Polymer conjugate of bioactive substance having hydroxy group |
03/21/2012 | EP2431362A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof |
03/21/2012 | EP2431355A1 New crystalline form vi of agomelatine, preparation method and application thereof |
03/21/2012 | EP2431041A1 Pharmaceutical composition for treating cardiovascular disorder and use thereof |
03/21/2012 | EP2431036A1 Macrocyclic lactone compounds and methods for their use |
03/21/2012 | EP2431033A1 Dronedarone for preventing cardiovascular hospitalization or mortality in patients with lone atrial fibrillation |
03/21/2012 | EP2430018A2 Benzoxazolone derivatives as aldosterone symthase inhibitors |
03/21/2012 | EP2429995A1 Aryl pyridine as aldosterone synthase inhibitors |
03/21/2012 | EP2429525A1 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm) |
03/21/2012 | EP2429519A1 Compositions and methods for treating ischemia and ischemia-reperfusion injury |
03/21/2012 | EP2133335B9 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
03/21/2012 | EP2118093B1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
03/21/2012 | EP1984345B9 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
03/21/2012 | EP1888103B1 Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling |
03/21/2012 | EP1506409B1 Assays for modulators of asparaginyl hydroxylase |
03/21/2012 | EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS |
03/21/2012 | EP1404412B1 Protein C for wound healing |
03/21/2012 | EP1313853B1 Modulation of fas and fasl expression by a synthetic phosphodiester oligonucleotide and an anti-fas antibody |
03/21/2012 | CN202169016U 合并胆经、心经两组织疾病的治疗装置 The combined treatment means gall bladder, heart disease, the two organizations |
03/21/2012 | CN202168960U 含有奥美沙坦酯、氨氯地平和氢氯噻嗪的复方制剂 Compound preparations containing olmesartan medoxomil, amlodipine and hydrochlorothiazide in |
03/21/2012 | CN1441770B Modified forms of pharmacologically active agents and uses therefor |
03/21/2012 | CN102388054A Thiazolopyridine sirtuin modulating compounds |
03/21/2012 | CN102387837A Use of rosuvastatin lactols as medicaments |
03/21/2012 | CN102387805A Use of ribose in first response to acute myocardial infarction |
03/21/2012 | CN102387803A Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease |
03/21/2012 | CN102387800A Rosuvastatin and atorvastatin derivatives |
03/21/2012 | CN102387799A Use of atorvastatin lactols as medicaments |
03/21/2012 | CN102382172A Binding agents which inhibit myostatin |
03/21/2012 | CN102382152A Method for preparing salidroside |
03/21/2012 | CN102382127A Myocardial small molecular compound for idiosyncratically promoting proliferation of myocardial cells and application thereof |
03/21/2012 | CN102382121A Ginkgolide derivative and application thereof to pharmacy |
03/21/2012 | CN102382113A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
03/21/2012 | CN102382102A Amide compound |
03/21/2012 | CN102382088A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
03/21/2012 | CN102382086A Process for preparing benzofurans |
03/21/2012 | CN102382076A Arone and arylamide compound and preparation method and medicine use thereof |
03/21/2012 | CN102382075A Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid |
03/21/2012 | CN102382037A Benzene propanoic acid compound and preparation method and medicine use thereof |
03/21/2012 | CN102382036A Phenoxyacetic acid compound, preparation method thereof and drug application |
03/21/2012 | CN102382032A 1-(phenyl)-4-[3-(4-indoxyl)-2-hydroxypropyl]piperazine derivative and salts thereof as well as preparation method and application thereof |
03/21/2012 | CN102380098A Combination therapy for the treatment of ocular neovascular disorders |
03/21/2012 | CN102380097A Peptide-based passive immunization therapy for treatment of atherosclerosis |
03/21/2012 | CN102380086A Medication for treating stroke and taking method thereof |
03/21/2012 | CN102380080A Herbal soup recipe for treatment of bleeding hemorrhoids |
03/21/2012 | CN102380078A Foot bath Chinese medical formula for preventing and assisting in treating varicose veins |
03/21/2012 | CN102380065A Traditional Chinese medicine for treating diabetic feet |
03/21/2012 | CN102380063A Chinese medicament for treating diabetic foot |
03/21/2012 | CN102380048A Traditional Chinese medicine composition for treating hypertension |
03/21/2012 | CN102380047A Medicine for treating cerebral hemorrhage and taking method |
03/21/2012 | CN102380045A Traditional Chinese medicine prescription for treating apoplexy due to kidney Yin deficiency |
03/21/2012 | CN102380033A Traditional Chinese medicine composition for treating chest discomfort, palpitation and cardiodynia |
03/21/2012 | CN102380032A Traditional Chinese medicine for treating diabetic heart disease |
03/21/2012 | CN102380011A Traditional Chinese medicine composition for treating polyarteritis nodosa |
03/21/2012 | CN102379997A Traditional Chinese medicinal composing prescription for treating hypertension |
03/21/2012 | CN102379981A Chinese medicament for treating diabetic heart disease |
03/21/2012 | CN102379980A Traditional Chinese medicine for treating diabetic heart diseases |
03/21/2012 | CN102379976A Traditional Chinese medicine for treating diabetic heart disease |
03/21/2012 | CN102379967A Traditional Chinese medicine for treating diabetic retinopathy |
03/21/2012 | CN102379961A Traditional Chinese medicine composition for treating stroke caused by deficiency of vital qi |
03/21/2012 | CN102379952A Traditional Chinese medicine cataplasm for preventing and treating phlebitis |
03/21/2012 | CN102379935A Composition for preventing or treating diseases caused by arteriosclerosis |
03/21/2012 | CN102379932A Anti-cardiovascular and cerebrovascular disease medicine |
03/21/2012 | CN102379910A New application for pien tze huang and preparation thereof in aspect of protecting memory function and resisting cerebral ischemia |
03/21/2012 | CN102379907A Ganoderma lucidum double vitamin methionine preparation and production method thereof |
03/21/2012 | CN102379896A Medicine composite for dehydrating, shrinking and eliminating lesion tissues |
03/21/2012 | CN102379892A Blood lipid regulation, antiatherosclerotic and anti-myocardial ischemia functions of clematichinenoside |
03/21/2012 | CN102379887A Cardiovascular disease treating medicament and preparation method and application thereof |
03/21/2012 | CN102379886A Scutellarin clinical preparation and preparation method thereof |